Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

Latest News

Date posted: 7/25/2013

For more than a year, DrugRisk has tracked the health warnings related to the popular atrial fibrillation anti-stroke medication Pradaxa, as well as growing lawsuits from those who suffered internal bleeding.

Now, a new study from Europe has suggested what over 1,000 patients are already claiming: taking Pradaxa can significantly increase the chances of a severe or fatal internal bleeding incident.

Pradaxa is a blood thinner approved by the FDA in 2010 to prevent blood clots and strokes in patients with atrial fibrillation. It became widely used as an alternative to traditional drugs warfarin and Coumadin, which require regular blood testing. In fact, German manufacturer Boehringer Ingelheim has boasted it is used in over 80 countries with more than $1 billion in sales.

However, experts have noted health risks from Pradaxa since the start. In just the first year on the market, more injuries and deaths were reported as linked to Pradaxa than 98% of all other meds. The Institute for Safe Medication Practices has repeatedly listed it among the most dangerous drugs, with patients nearly 5 times as likely to die from bleeding with Pradaxa than from warfarin.

Researchers at the University of Illinois at Chicago also advised that the risk for Pradaxa bleeding may be higher than thought.

Now, a study published this month from the Netherlands suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding than with traditional drugs like warfarin.

Regrettably, however, the FDA continues to tell consumers that Pradaxa is no more dangerous than warfarin.

Since there is no Pradaxa recall, the only recourse for those injured by internal bleeding is to file a Pradaxa lawsuit.

With lawsuits growing quickly, they have been consolidated to a special federal court in Illinois. According to the latest court records, 1,133 people have now filed a Pradaxa lawsuit, up from 663 just two months ago.

If you or a family member were injured by internal bleeding after taking Pradaxa, it is important to learn about your legal options before your rights expire. Lawyers are available to discuss your case today at no cost.

However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits. Contact us today for more information or to speak with a lawyer.